| P50 | author | Yisrael Parmet | Q58856659 |
| | Arik Eisenkraft | Q88103315 |
| | Yossi Rosman | Q115760783 |
| | Michael Kassirer | Q115760784 |
| | Nadav Milk | Q115760790 |
| P2093 | author name string | Alon Friedman | |
| | Yoash Chassidim | |
| | Yonatan Serlin | |
| | Guy Bar-Klein | |
| | Ronel Veksler | |
| | Svetlana Lublinsky | |
| | Vladimir V Senatorov | |
| | Daniela Kaufer | |
| | Lyn Kamintsky | |
| | Iris Noyman | |
| | Hotjensa Dalipaj | |
| | Dror Rosenbach | |
| | Dan Z Milikovsky | |
| | Evyatar Swissa | |
| | Netta Elazary | |
| P2860 | cites work | Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy | Q26824659 |
| | Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 |
| | Modification of seizure activity by electrical stimulation. II. Motor seizure | Q28236678 |
| | Characterization of status epilepticus induced by two organophosphates in rats | Q28387562 |
| | The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 |
| | Advances in the development of biomarkers for epilepsy. | Q30249613 |
| | Epilepsy biomarkers. | Q30411290 |
| | Quantitative imaging assessment of blood-brain barrier permeability in humans. | Q30587216 |
| | Analyzing the blood-brain barrier: the benefits of medical imaging in research and clinical practice | Q30873284 |
| | Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging | Q30889701 |
| | A novel, noninvasive, predictive epilepsy biomarker with clinical potential | Q33801568 |
| | Losartan prevents acquired epilepsy via TGF-β signaling suppression | Q33831494 |
| | A crucial epileptogenic site in the deep prepiriform cortex | Q34051474 |
| | The role of the piriform cortex in kindling | Q34064097 |
| | Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. | Q34346791 |
| | The blood-brain barrier and epilepsy | Q34583073 |
| | TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis | Q34583749 |
| | Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy | Q34584249 |
| | Organophosphate poisoning | Q34730002 |
| | Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model | Q35164863 |
| | Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction | Q35588910 |
| | Isoflurane protects against human endothelial cell apoptosis by inducing sphingosine kinase-1 via ERK MAPK. | Q35719530 |
| | Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy | Q37442196 |
| | Epilepsy in 2011: Insights into epilepsy treatments and biomarkers | Q37974489 |
| | Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus | Q38260091 |
| | Should losartan be administered following brain injury? | Q38262865 |
| | Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study | Q39298425 |
| | PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. | Q39523354 |
| | Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging | Q40183729 |
| | Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats II: Potential mechanisms. | Q40183907 |
| | Isoflurane prevents acquired epilepsy in rat models of temporal lobe epilepsy | Q40497360 |
| | Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? | Q40705824 |
| | Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis | Q40705985 |
| | Reduced thalamocortical functional connectivity in temporal lobe epilepsy | Q40716203 |
| | Differential TGF-β Signaling in Glial Subsets Underlies IL-6-Mediated Epileptogenesis in Mice. | Q40774504 |
| | Isoflurane on brain inflammation | Q41941056 |
| | Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment | Q42705486 |
| | The role of the substantia nigra pars reticulata in kindling resistance in rats with genetic absence epilepsy. | Q43196329 |
| | Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings | Q44530106 |
| | Opening of the blood-brain barrier during isoflurane anaesthesia. | Q46273319 |
| | Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats | Q46707903 |
| | Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy | Q48162534 |
| | Blood-brain barrier opening to large molecules does not imply blood-brain barrier opening to small ions | Q48224618 |
| | Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex | Q48328276 |
| | Imaging blood-brain barrier dysfunction in football players | Q48460803 |
| | sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats. | Q48463164 |
| | Paraoxon: Effects on Rat Brain Cholinesterase and on Growth Hormone and Prolactin of Pituitary | Q48787227 |
| | Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent | Q50244576 |
| | Blood-brain barrier disruption in post-traumatic epilepsy. | Q54331689 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood–brain barrier | Q221694 |
| | biomarker | Q864574 |
| P304 | page(s) | 1692-1705 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis | |
| P478 | volume | 140 | |